2018 Investment in Cancer Research: Report Released
Today, CCRA released its latest report on the investment in cancer research. It reveals that $491M was invested in cancer research in 2018. Although a slight increase since 2017 (up $17M), the investment has been fairly constant over the past five years.
This year’s report includes some new analyses, which quantify the cancer-related health services and policy research (HSPR) investment for the five-year period, 2014-2018. The investment in cancer-related HSPR represented 5% of the overall cancer research investment for this period, with a fairly stable annual amount of between $26M to $27M.
The report has an accompanying slide deck and Excel file that expand on the report analyses. To access the annual report and companion documents, click here.
Article Published on PIP Grant Adjudication
Today in the Journal of Patient Experience, an article on the 2021 inaugural PIP grant adjudication was published by the 2021 PIP Working Group. Thanks to our PIP supporters!
Acc... Read More »
Today in the Journal of Patient Experience, an article on the 2021 inaugural PIP grant adjudication was published by the 2021 PIP Working Group. Thanks to our PIP supporters!
Acc... Read More »
Outstanding Contributions to the Canadian Cancer Research Community
Today, the CCRA recognizes six leaders in Canadian cancer research, including two inaugural Indigenous awards recipients. The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on ... Read More »
Today, the CCRA recognizes six leaders in Canadian cancer research, including two inaugural Indigenous awards recipients. The CCRA Awards, initiated in 2011, recognize and celebrate on a biennial basis the outstanding contributions of individuals who have had a remarkable impact on ... Read More »